Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Toluene | HCID 1140 | — |
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | Dimethylacetamide | HCID 31374 | — |
| Reactant | 4-Methyl-5-((2R)-oxiran-2-yl)-2-benzofuran-1(3H)-one | HCID 59568646 | — |
| Product | 1255204-84-2 | HCID 59568713 | — |
Reaction Steps
piperazine (4.51 g, 52.4 mmol) and 4-methyl-5-[(2R)-oxiran-2-yl]-2-benzofuran-1(3H)-one (20.0 g, 105 mmol) were charged to a 3-neck 500-mL roundbottom flask, equipped with a reflux condensor, under nitrogen. Toluene (80.0 mL, 751 mmol) and N,N-dimethylacetamide (80 mL, 854 mmol) were added to provide a suspension. The reaction mixture was warmed to 110° C., becoming homogeneous at 25° C. After stirring for 4.5 h at 110° C., the temperature was increased to 115° C. to drive the reaction forward. After stirring for 48 h, the reaction mixture was cooled to RT. On cooling, crystallization occurred. Water was added via addition funnel (45 mL), generating a thick slurry. The suspension was filtered and the solids were washed with 4:1 water:DMA (60 mL), followed by water (2×35 mL). The solid was dried on the funnel under vacuum with a nitrogen sweep to constant mass. 5,5′-{piperazine-1,4-diylbis[(1R)-1-hydroxyethane-2,1-diyl]}bis(4-methyl-2-benzofuran-1(3H)-one) was isolated.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09018211B2 |
|---|
| Source dataset | uspto-grants-2015_04 |
|---|
| ORD ID | ord-2f2dfda8215e49d190b69db0902b5bbd |
|---|
| Source note | uspto-grants-2015_04 |
|---|